- Home
- LGHL vs PRFX Comparison
LGHL vs PRFX Comparison
Compare LGHL & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGHL | PRFX |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 1.8M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LGHL | PRFX |
|---|---|---|
| Price | $3.48 | $0.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 740.8K | 147.3K |
| Earning Date | 04-30-2024 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.32 | $0.80 |
| 52 Week High | $213.20 | $16.63 |
Technical Indicators
Market Signals| Indicator | LGHL | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 49.64 | 42.38 |
| Support Level | $3.32 | $0.85 |
| Resistance Level | $8.92 | $1.00 |
| Average True Range (ATR) | 1.15 | 0.10 |
| MACD | -0.30 | 0.01 |
| Stochastic Oscillator | 2.32 | 9.82 |
Price Performance
Historical ComparisonAbout LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.